Retroviral-mediated gene transduction of c-kit into single hematopoietic progenitor cells from cord blood enhances erythroid colony formation and decreases sensitivity to inhibition by tumor necrosis factor-α and transforming growth factor-β1

Blood

Volumn 94, Issue 7, 1999, Pages 2319-2332

  Lu, Li ^a   Heinrich, Michael C ^b   Wang, Li Sheng ^b   Dai, Mu Shui ^b   Zigler, Amy J ^b   Chai, Lin ^b   Broxmeyer, Hal E ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ARTICLE; CELL PROLIFERATION; ERYTHROPOIESIS; GENE TARGETING; GENETIC TRANSDUCTION; GROWTH STIMULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS;

EID: 0033215520     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.7.2319.419k14_2319_2332     Document Type: Article

References (63)

1. Russell ES: Hereditary anemias of the mouse: A review for geneticists. Adv Genet 20:357, 1979
2. Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987
3. Besmer P, Murphy JE, George PC, Qiu F, Bergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE, Hardy WD: A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415, 1986
4. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
5. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S-I, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S-I: Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med 174:63, 1991
6. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa S-I, Miura Y, Suda T: Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706, 1991
7. Katayama N, Shih J-P, Nishikawa S-I, Kina T, Clark SC, Ogawa M: Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 82:2353, 1993
8. De Jong MO, Wagemaker G, Wognum AW: Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood 86:4076, 1995
9. low cells in which anti-TGF-β upmodulates c-kit. Blood 86:1729, 1995
10. 3+ cord blood cells changes the differentiation profile of daughter progenitors. J Leukoc Biol 63:389, 1998
11. Williams DE, Eisenman J, Baird A, Rauch C, Ness KV, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 63:167, 1990
12. Flanagan JG, Leder P: The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell 63:185, 1990
13. Huang E, Nocka K, Beier DR, Chu T-Y, Buck J, Lahm H-W, Wellner D, Leder P, Besmer P: The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
14. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand of the c-kit tyrosine kinase receptor. Cell 63:213, 1990
15. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235, 1990
16. Heinrich MC, Dooley DC, Freed AC, Band L, Hoatlin ME, Keeble WW, Peters ST, Silvey KV, Ey FS, Kabat D, Maziarz RT, Bagby GC Jr: Constitutive expression of Steel factor gene by human stromal cells. Blood 82:771, 1993
17. Aye MT, Hashemi S, Leclair B, Zeibdawi A, Trudel E, Halpenny M, Fuller V, Cheng G: Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 20:523, 1992
18. 41 and W. EMBO J 9:1805, 1990
19. Kodama H, Nose M, Yamaguchi Y, Tsunoda J-I, Suda T, Nishikawa S, Nishikawa S-I: In vitro proliferation of primitive hemopoietic stem cells supported by stromal cells: Evidence for the presence of a mechanism(s) other than that involving c-kit receptor and its ligand. J Exp Med 176: 351, 1992
20. Wineman JP, Nishikawa S-I, Muller-Sieburg CE: Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: Effect of stromal cells and c-kit. Blood 81:365, 1993
21. Migliaccio AR, Migliaccio G, Mancini G, Ratajczak M, Gewirtz AM, Adamson JW: Induction of the murine "W phenotype" in long-term cultures of human cord blood cells by c-kit antisense oligomers. J Cell Physiol 157:158, 1993
22. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
23. Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massague J: Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells. Nature 329:539, 1987
24. Massague J, Heino J, Laiho M: Mechanisms in TGF-β action. Ciba Found Symp 157:51, 1991
25. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63:245, 1990
26. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB: Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84:6020, 1987
27. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures: I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96, 1990
28. McNiece IK, Bertoncello I, Keller JR, Ruscetti FW, Hartley CA, Zsebo KM: Transforming growth factor β inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning 10:80, 1992
29. +++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp Hematol 21:1442, 1993
30. Migdalska A, Molineux G, Demuynck H, Evans GS, Ruscetti F, Dexter TM: Growth inhibitory effects of transforming growth factor-beta1 in vivo. Growth Factors 4:239, 1991
31. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR: Transforming growth factor β is a potent inhibitor of interleukin 1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action. J Exp Med 172:737, 1990
32. Jacobsen SEW, Ruscetti FW, Roberts AB, Keller JR: TGF-β is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-β1 and TGF-β3. J Immunol 151:4534, 1993
33. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol 17:2458, 1997
34. Ravitz MJ, Van S, Dolce C, Kinniburgh AJ, Wenner CE: Differential regulation of p27 and cyclin D1 by TGF-β and EGF in C3H 10T1/2 mouse fibroblasts. J Cell Physiol 168:510, 1996
35. Reynisdottir I, Polyak K, Iavarone A, Massague J: Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831, 1995
36. Li C-Y, Suardet L, Little JB : Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 270:4971, 1995
37. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175, 1990
38. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY: The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia. Synergism of tumor necrosis factor and interferon-γ. J Immunol 136:4487, 1986
39. Lu L, Welte K, Gablilove JL, Hangoc G, Bruno E, Hoffman R, Broxmeyer HE: Effects of recombinant human tumor necrosis factor α, recombinant human interferon-γ, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony stimulating factor, pluripoietin-alpha and recombinant erythropoietin in serum-free cultures. Cancer Res 46:4357, 1986
40. c by IL-1 and tumor necrosis factor-α. Blood 80:2215, 1992
41. Elbaz O, Budel LM, Hoogerbrugge H, Touw IP, Delwel R, Mahmoud LA, Lownenberg B: Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. J Clin Invest 87:838, 1991
42. + cells via p55 TNFα receptors. Blood 84:2506, 1994
43. Brach MA, Buhring H-J, Gruβ H-J, Ashman LK, Ludwig W-D, Mertelsmann RH, Herrmann F: Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-α through posttranscriptional mRNA stabilization by a labile protein. Blood 80:1224, 1992
44. Jacobsen FW, Dubois CM, Rusten LS, Veiby OP, Jacobsen SEW: Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression. J Immunol 154:3732, 1995
45. +++ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41, 1993
46. +++ hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 178:2089, 1993
47. Lu L, Ge Y, Li Z-H, Keeble W, Kabat D, Bagby GC, Broxmeyer HE, Hoatlin M: Retroviral transfer of the recombinant human erythopoietin receptor gene into single hematopoietic stem/progenitor cells from human cord blood increases the number of erythropoietin-dependent erythroid colonies. Blood 87:525, 1996
48. GF-or low cord blood cells on cytokine-stimulated erythroid colony formation. Exp Hematol 24:347, 1996
49. Xiao M, Yang Y-C, Yang L, Chang M-S, Cornetta K, Broxmeyer HE, Lu L: Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies. Bone Marrow Transplant 18:1103, 1996
50. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790, 1995
51. Reith AD, Ellis C, Lyman SD, Anderson DM, Williams DE, Bernstein A, Pawson T: Signal transduction by normal isoforms and W mutant variants of the kit receptor tryrosine kinase. EMBO J 10:2451, 1991
52. Heinrich MC, Dooley DC, Keeble WW: Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769, 1995
53. Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ, Sposi NM, Guerriero R, Rosato V, Gabbianelli M, Pelosi E, Valtieri M, Peschle C: Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 88:3391, 1996
54. Negoescu A, Lorimier P, Labat-Molieur F, Azoti L, Robert C, Guillermet C, Brambilla C, Brambilla E: TUNEL: Improvement and evaluation of the method for in situ apoptotic cell identification. Biochemica 2:12, 1997
55. Lowry PA, Deacon D, Whitefield P, McGrath HE, Quesenberry PJ: Stem cell factor induction of in vitro murine hematopoietic colony formation by "subliminal" cytokine combinations: The role of "anchor factors." Blood 80:663, 1992
56. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138, 1994
57. Timeus F, Crescenzio N, Valle P, Pistamiglio P, Piglione M, Garelli E, Ricotti E, Rocchi P, Strippoli P, di Montezemolo LC, Madon E, Ramenghi U, Basso G: Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Exp Hematol 25:1253, 1997
58. + marrow cells. Blood 86:2161, 1995
59. de Vos S, Brach MA, Asano Y, Ludwig W-D, Bettelheim P, Gruss H-J, Herrmann F: Transforming growth factor-β1 interferes with the proliferation-inducing activity of stem cell factor in myelogeneous leukemia blasts through functional down-regulation of the c-kit protooncogene product. Cancer Res 53:3638, 1993
60. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 11:492, 1997
61. Kaushansky K, Broudy VC, Harlan JM, Adamson JW: Tumor necrosis factor-α and tumor necrosis factor-β (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo. J Immunol 141:3410, 1988
62. Zhang Y, Harada A, Bluethmann H, Wang J-B, Nakao S, Mukaida N, Matsushima K: Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: Increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF α in vitro. Blood 86:2930, 1995
63. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP: Interferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165:538, 1995